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As metabolism is considered a main cause for adverse
drug reactions and failures of new drug candidates, our
goal is to establish an in silico method to efficiently pre-
dict phase II metabolism – in particular sulfotransferase
(SULT) activity. Since sulfotransferases exhibit low sub-
strate specificities caused by their high degree of confor-
mational freedom [1], activity prediction is a challenging
task.
We therefore established a workflow based on mole-
cular dynamics (MD) simulations to cover the whole
spectrum of structural flexibility and incorporated it
into multiple pharmacophores that represent specific
modes of action. Using an ensemble of pharmacophores
for virtual screening ensures accurate categorization of
potential SULT ligands (e.g. substrates, inhibitors).
Recent advances in MD technology [2] allowed for
refinement of these pharmacophores by high-throughput
MD simulations of ligand-target complexes. In addition,
the initial binding process of a soluble ligand to the sub-
strate-binding site of SULT was captured in unbiased
100 ns simulations using the software Desmond [3].
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